# Items by Jennison, Christopher

Up a level |

Number of items:

**33**.## Book/s

Jennison, C. and Turnbull, B. W., 2000.

*Group sequential tests with applications to clinical trials.*Chapman Hall/CRC.## Book Sections

Jennison, C., Antonijevic, Z., Bolognese, J., Burman, C.-F., Chuang-Stein, C., Kimber, M., Marchenko, O., Patel, N. and Pinheiro, J., 2015. Impact of Phase 2b strategies on optimization of drug development programs.

*In*:*Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy.*Heidelberg: Springer, pp. 83-103.## Articles

Parke, T., Marchenko, O., Anisimov, V., Ivanova, A., Jennison, C., Perevozskaya, I. and Song, G., 2017. Comparing oncology clinical programs by use of innovative designs and expected net present value optimization:which adaptive approach leads to the best result?

*Journal of Biopharmaceutical Statistics*Wason, J., Stallard, N., Bowden, J. and Jennison, C., 2017. A multi-stage drop-the-losers design for multi-arm clinical trials.

*Statistical Methods in Medical Research*, 26 (1), pp. 508-524.Jennison, C. and Turnbull, B. W., 2015. Adaptive sample size modification in clinical trials:start small then ask for more?

*Statistics in Medicine*, 34 (29), pp. 3793-3810.Jennison, C. and Hampson, L., 2015. Optimising the Data Combination Rule for Seamless Phase II/III Clinical Trials.

*Statistics in Medicine*, 34 (1), pp. 39-58.Stone, A., Macpherson, E., Smith, A. and Jennison, C., 2015. Model free audit methodology for bias evaluation of tumour progression in oncology.

*Pharmaceutical Statistics*, 14 (6), pp. 455-463.Zhou, K., Donnelly, L.A., Morris, A.D., Franks, P.W., Jennison, C., Palmer, C.N.A. and Pearson, E.R., 2014. Clinical and genetic determinants of progression of type 2 diabetes:A direct study.

*Diabetes Care*, 37 (3), pp. 718-724.Hampson, L. V. and Jennison, C., 2013. Group sequential tests for delayed responses (with discussion).

*Journal of the Royal Statistical Society, Series B (Statistical Methodology)*, 75 (1), pp. 3-54.Jennison, C. and Turnbull, B. W., 2013. Interim monitoring of clinical trials:decision theory, dynamic programming and optimal stopping.

*Kuwait Journal of Science*, 40 (2), pp. 43-59.Jenkins, M., Stone, A. and Jennison, C., 2011. An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints.

*Pharmaceutical Statistics*, 10 (4), pp. 347-356.Khorsheed, E., Hurn, M. and Jennison, C., 2011. Mapping electron density in the ionosphere: a principal component MCMC algorithm.

*Computational Statistics & Data Analysis*, 55 (1), pp. 338-352.Al-Awadhi, F., Hurn, M. and Jennison, C., 2011. Three-dimensional Bayesian image analysis and confocal microscopy.

*Journal of Applied Statistics*, 38 (1), pp. 29-46.Ohrn, F. and Jennison, C., 2010. Optimal group-sequential designs for simultaneous testing of superiority and non-inferiority.

*Statistics in Medicine*, 29 (7-8), pp. 743-759.Jennison, C. and Turnbull, B. W., 2007. Adaptive seamless designs: Selection and prospective testing of hypotheses.

*Journal of Biopharmaceutical Statistics*, 17 (6), pp. 1135-1161.Jennison, C. and Turnbull, B. W., 2006. Efficient group sequential designs when there are several effect sizes under consideration.

*Statistics in Medicine*, 25 (6), pp. 917-932.Jennison, C. and Turnbull, B. W., 2006. Adaptive and nonadaptive group sequential tests.

*Biometrika*, 93 (1), pp. 1-21.Jennison, C. and Turnbull, B. W., 2006. Are flexible designs sound? Discussion.

*Biometrics*, 62 (3), pp. 670-673.Jennison, C. and Turnbull, B. W., 2006. Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: Opportunities and limitations.

*Biometrical Journal*, 48 (4), pp. 650-655.Jennison, C. and Turnbull, B. W., 2006. Discussion of "Executive Summary of the PhRMA Working Group on adaptive designs in clinical drug development".

*Journal of Biopharmaceutical Statistics*, 16 May-Jun (3), pp. 293-298.Jennison, C. and Turnbull, B. W., 2005. Meta-analyses and adaptive group sequential designs in the clinical development process.

*Journal of Biopharmaceutical Statistics*, 15 (4), pp. 537-558.Al-Awadhi, F., Jennison, C. and Hurn, M., 2004. Statistical image analysis for a confocal microscopy two-dimensional section of cartilage growth.

*Journal of the Royal Statistical Society Series C-Applied Statistics*, 53 (1), pp. 31-49.Al-Awadhi, F., Hurn, M. and Jennison, C., 2004. Improving the acceptance rate of reversible jump MCMC proposals.

*Statistics & Probability Letters*, 69 (2), pp. 189-198.Yong, P. F. K., Milner, P. C., Payne, J. N., Lewis, P. A. and Jennison, C., 2004. Inequalities in access to knee joint replacements for people in need.

*Annals of the Rheumatic Diseases*, 63 (11), pp. 1483-1489.Milner, P. C., Payne, J. N., Stanfield, R. C., Lewis, P. A., Jennison, C. and Saul, C., 2004. Inequalities in accessing hip joint replacement for people in need.

*European Journal of Public Health*, 14 (1), pp. 58-62.Jennison, C. and Turnbull, B. W., 2003. Mid-course sample size modification in clinical trials based on the observed treatment effect.

*Statistics in Medicine*, 22 (6), pp. 971-993.Leonard, L., Williamson, D. M., Ivory, J. P. and Jennison, C., 2003. An evaluation of the safety and efficacy of simultaneous bilateral total knee arthroplasty.

*Journal of Arthroplasty*, 18 (8), pp. 972-978.Robert, C. P., Meng, X. L., Moller, J., Rosenthal, J. S., Jennison, C., Hurn, M. A., Al-Awadhi, F., McCullagh, P., Andrieu, C., Doucet, A., Dellaportas, P., Papageorgiou, I., Ehlers, R. S., Erosheva, E. A., Fienberg, S. E., Forster, J. J., Gill, R. C., Friel, N., Green, P., Hastie, D., King, R., Kunsch, H. R., Lazar, N. A. and Osinski, C., 2003. Efficient construction of reversible jump Markov chain Monte Carlo proposal distributions - Discussion on the paper by Brooks, Giudici and Roberts.

*Journal of the Royal Statistical Society, Series B (Statistical Methodology)*, 65, pp. 39-55.Arjas, E., Jennison, C., Dawid, A. P., Cox, D. R., Cowell, R. G., Didelez, V., Gill, R. D., Kadane, J. B. and Robins, J. M., 2003. Optimal dynamic treatment regimes - Discussion on the paper by Murphy.

*Journal of the Royal Statistical Society, Series B (Statistical Methodology)*, 65, pp. 355-366.Barber, S. and Jennison, C., 2002. Optimal asymmetric one-sided group sequential tests.

*Biometrika*, 89 (1), pp. 49-60.Molchanov, I., Jennison, C., Ersboll, B. K., Hancock, E., Wilson, R., Horgan, G., Kent, J. T., Ashburner, J., Dryden, I. L., Petrou, M., Angulo, J. M., Berman, M., Coleman, R., Duta, N., Jain, A. K., Ghosh, J. K., Murthy, C. A., Gray, A., Gustafsson, J., Rudemo, M., Hogg, D., Koch, I., Linney, A., Ramsay, J. O., Ramsay, T. O., Rao, M. M., Sebastiani, G., de Souza, K., Sun, C. M., Buckley, M., Titterington, D. M., Trubuil, A., Worsley, K. J. and Yu, K. M., 2001. A penalized likelihood approach to image warping - Discussion.

*Journal of the Royal Statistical Society, Series B (Statistical Methodology)*, 63, pp. 492-514.Jennison, C. and Turnbull, B. W., 2001. On group sequential tests for data in unequally sized groups and with unknown variance.

*Journal of Statistical Planning and Inference*, 96 (1), pp. 263-288.Jennison, C. and Turnbull, B. W., 1997. Group-sequential analysis incorporating covariate information.

*Journal of the American Statistical Association*, 92 (440), pp. 1330-1341.